|
|||||
|
|
Sodium-glucose co-transporter-2 inhibitors and susceptibility to COVID-19: A population-based retrospective cohort study |
|
| Authors: | Christopher Sainsbury MD Jingya Wang PhD Krishna Gokhale MSc Dionisio Acosta-Mena PhD Samir Dhalla MRPharmS Nathan Byne Joht Singh Chandan PhD Astha Anand BMBCh Jennifer Cooper MBBCh Kelvin Okoth MPH Anuradhaa Subramanian MSc Mansoor N. Bangash PhD Thomas Taverner PhD Wasim Hanif PhD Sandip Ghosh FRCP Parth Narendran PhD Kar K. Cheng PhD Tom Marshall PhD Georgios Gkoutos PhD Konstantinos Toulis PhD Neil Thomas PhD Abd Tahrani PhD Nicola J. Adderley PhD Shamil Haroon PhD Krishnarajah Nirantharakumar MD |
| Affiliation: | 1. Institute of Applied Health Research, University of Birmingham, Birmingham, UK;2. Institute of Applied Health Research, University of Birmingham, Birmingham, UK Christopher Sainsbury, Jingya Wang and Krishna Gokhale authors are contributed equally.;3. Cegedim Health Data, Cegedim Rx, London, UK;4. The Health Improvement Network (THIN), London, UK;5. Institute of Clinical Sciences, University of Birmingham, Birmingham, UK Department of Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK;6. Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK;7. Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK;8. Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK;9. Institute of Applied Health Research, University of Birmingham, Birmingham, UK Joint Senior Authors.;10. Institute of Applied Health Research, University of Birmingham, Birmingham, UK Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK Midlands Health Data Research UK, Birmingham, UK Joint Senior Authors. |
| Abstract: | |
| Keywords: | antidiabetic drug DPP-4 inhibitor pharmaco-epidemiology SGLT2 inhibitor type 2 diabetes |